Jia Jie Biomedical Co Ltd (4109) — Capital Reinvestment Ratio
Jia Jie Biomedical Co Ltd (4109) has a Capital Reinvestment Ratio of 2.51x as of December 2025, meaning it reinvests 3% of its operating cash flow (NT$11.32 Million) in capital expenditures (NT$28.47 Million). See how much free cash does Jia Jie Biomedical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jia Jie Biomedical Co Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks Jia Jie Biomedical Co Ltd's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Jia Jie Biomedical Co Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for Jia Jie Biomedical Co Ltd from 2015 to 2025. For live market cap and broader valuation context, see Jia Jie Biomedical Co Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.01x | NT$21.34 Million | NT$85.50 Million | ▲ +805.1% |
| 2024 | 0.44x | NT$44.35 Million | NT$19.63 Million | ▲ +27.4% |
| 2021 | 0.35x | NT$4.37 Million | NT$1.52 Million | ▲ +476.4% |
| 2020 | 0.06x | NT$27.10 Million | NT$1.63 Million | ▼ -51.2% |
| 2019 | 0.12x | NT$24.71 Million | NT$3.05 Million | ▼ -96.3% |
| 2015 | 3.33x | NT$82.22 Million | NT$273.85 Million | — |